| Novel quinoline and naphthalene derivatives as potent antimycobacterial agents RS Upadhayaya, JK Vandavasi, RA Kardile, SV Lahore, SS Dixit, ... European journal of medicinal chemistry 45 (5), 1854-1867, 2010 | 144 | 2010 |
| 3D-QSAR of histone deacetylase inhibitors: hydroxamate analogues DC Juvale, VV Kulkarni, HS Deokar, NK Wagh, SB Padhye, VM Kulkarni Organic & Biomolecular Chemistry 4 (15), 2858-2868, 2006 | 69 | 2006 |
| Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl) pyrimidines as COX-2 inhibitors UA Shah, HS Deokar, SS Kadam, VM Kulkarni Molecular diversity 14, 559-568, 2010 | 64 | 2010 |
| Synthesis and structure–activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel N Rodrigues, K Bennis, D Vivier, V Pereira, FC Chatelain, E Chapuy, ... European journal of medicinal chemistry 75, 391-402, 2014 | 43 | 2014 |
| Inhibition of gastric tumor growth by a novel Hsp90 inhibitor C Lu, D Liu, J Jin, H Deokar, Y Zhang, JK Buolamwini, X Yu, C Yan, ... Biochemical pharmacology 85 (9), 1246-1256, 2013 | 33 | 2013 |
| 3D-QSAR of histone deacetylase inhibitors as anticancer agents by genetic function approximation NK Wagh, HS Deokar, DC Juvale, SS Kadam, VM Kulkarni NISCAIR-CSIR, India, 2006 | 26 | 2006 |
| Inhibiting β-catenin by β-carboline-type MDM2 inhibitor for pancreatic cancer therapy JJ Qin, W Wang, X Li, H Deokar, JK Buolamwini, R Zhang Frontiers in pharmacology 9, 5, 2018 | 25 | 2018 |
| Synthesis, biological evaluation and modeling studies of new pyrido [3, 4-b] indole derivatives as broad-spectrum potent anticancer agents SA Patil, JK Addo, H Deokar, S Sun, J Wang, W Li, DP Suttle, W Wang, ... Drug designing: open access 6 (1), 2017 | 22 | 2017 |
| Targeted brain tumor therapy by inhibiting the MDM2 oncogene: In vitro and in vivo antitumor activity and mechanism of action SR Punganuru, V Arutla, W Zhao, M Rajaei, H Deokar, R Zhang, ... Cells 9 (7), 1592, 2020 | 15 | 2020 |
| QSAR studies of new pyrido[3,4-b]indole derivatives as inhibitors of colon and pancreatic cancer cell proliferation H Deokar, M Deokar, W Wang, R Zhang, JK Buolamwini Medicinal Chemistry Research 27, 2466-2481, 2018 | 14 | 2018 |
| QSAR analysis of N-myristoyltransferase inhibitors: antifungal activity of benzofurans HS Deokar, P Puranik, VM Kulkarni Medicinal chemistry research 18, 206-220, 2009 | 14 | 2009 |
| SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo Y Wang, C Yang, MM Sims, JR Sacher, M Raje, H Deokar, P Yue, ... Cancer Letters 533, 215614, 2022 | 12 | 2022 |
| Identification of PDZ ligands by docking-based virtual screening for the development of novel analgesic agents N Bouzidi, H Deokar, A Vogrig, B Boucherle, I Ripoche, ... Bioorganic & medicinal chemistry letters 23 (9), 2624-2627, 2013 | 12 | 2013 |
| Synthesis and evaluation of bidentate ligands designed to interact with PDZ domains B Boucherle, A Vogrig, H Deokar, N Bouzidi, I Ripoche, I Thomas, P Marin, ... Bioorganic & medicinal chemistry 19 (14), 4346-4354, 2011 | 11 | 2011 |
| NMR evaluation of interactions between substituted-indole and PDZ1 domain of PSD-95 A Vogrig, B Boucherle, H Deokar, I Thomas, I Ripoche, LY Lian, S Ducki Bioorganic & medicinal chemistry letters 21 (11), 3349-3353, 2011 | 9 | 2011 |
| 3D-QSAR and pharmacophore identification of novel imidazolyl benzimidazoles and imidazo [4, 5-b] pyridines as potent p38 mitogen activated protein kinase inhibitors UA Shah, HS Deokar, SS Kadam, VM Kulkarni Int. J. Chem. Tech. Res 2 (1), 194-202, 2010 | 9 | 2010 |
| Targeting MDM2 for neuroblastoma therapy: in vitro and in vivo anticancer activity and mechanism of action W Wang, X Wang, M Rajaei, JY Youn, A Zafar, H Deokar, JK Buolamwini, ... Cancers 12 (12), 3651, 2020 | 8 | 2020 |
| Homology modeling of human concentrative nucleoside transporters (hCNTs) and validation by virtual screening and experimental testing to identify novel hCNT1 Inhibitors HK Deokar, HP Barch, JK Buolamwini Drug designing: open access 6 (1), 2017 | 8 | 2017 |
| A quantitative LC-MS/MS method for determination of SP-141, a novel pyrido [b] indole anticancer agent, and its application to a mouse PK study S Nag, JJ Qin, S Patil, H Deokar, JK Buolamwini, W Wang, R Zhang Journal of Chromatography B 969, 235-240, 2014 | 8 | 2014 |
| 3d-QSAR of Biphenyl Analogues as Anti-Inflammatory Agents by Genetic Function Approximation (GFA)(Part-II.) UA Shah, NK Wagh, HS Deokar, SS Kadam, VM Kulkarni Int. J. Pharm. Bio. Sci 1, 512-522, 2010 | 6 | 2010 |
Ruiwen ZhangProfessor of Pharmacology and Toxicology, Robert L. Boblitt Endowed Professor in Drug DiscoveryVerified email at central.uh.edu
